A longitudinal study of SARS-CoV-2 antibody seroprevalence and mitigation behaviors among college students at an Arkansas University.
J Am Coll Health
; : 1-10, 2023 Jun 08.
Article
em En
| MEDLINE
| ID: mdl-37289962
ABSTRACT
Objective:
Assess university students' SARS-CoV-2 antibody seroprevalence and mitigation behaviors over time.Participants:
Randomly selected college students (N = 344) in a predominantly rural Southern state.Methods:
Participants provided blood samples and completed self-administered questionnaires at three timepoints over the academic year. Adjusted odds ratios and 95% confidence intervals were estimated from logistic regression analyses.Results:
SARS-CoV-2 antibody seroprevalence was 18.2% in September 2020, 13.1% in December, and 45.5% in March 2021 (21% for those with no vaccination history). SARS-CoV-2 antibody seroprevalence was associated with large social gatherings, staying local during the summer break, symptoms of fatigue or rhinitis, Greek affiliation, attending Greek events, employment, and using social media as the primary COVID-19 information source. In March 2021, seroprevalence was associated with receiving at least one dose of a COVID-19 vaccination.Conclusion:
SARS-CoV-2 seroprevalence was higher in this population of college students than previous studies. Results can assist leaders in making informed decisions as new variants threaten college campuses.
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
J Am Coll Health
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Estados Unidos